Vyant Bio, Inc. (OTCMKTS:VYNT – Get Free Report) shares rose 7.8% during mid-day trading on Friday . The stock traded as high as $0.20 and last traded at $0.19. Approximately 19,100 shares changed hands during trading, a decline of 88% from the average daily volume of 161,822 shares. The stock had previously closed at $0.18.
Vyant Bio Trading Up 7.8 %
The firm has a fifty day moving average price of $0.19 and a 200-day moving average price of $0.19. The company has a current ratio of 2.86, a quick ratio of 2.86 and a debt-to-equity ratio of 0.04.
About Vyant Bio
Vyant Bio, Inc, a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD).
See Also
- Five stocks we like better than Vyant Bio
- What is the Australian Securities Exchange (ASX)
- MarketBeat Week in Review – 5/6 – 5/10
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Bounce Alert: 3 Large Caps With RSIs Too Good To Ignore
- What is an Earnings Surprise?
- Unity Software’s Mixed Q1, But Long-Term Outlook Remains Positive
Receive News & Ratings for Vyant Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vyant Bio and related companies with MarketBeat.com's FREE daily email newsletter.
